Two GEMM models were down-classified to the ‘low’ category, with one study reporting the accidental development of RMS in an ovarian cancer mouse model due to non-specific genetic manipulation (19), and the other study reporting IGF-2 overexpressing pelvic RMS with concomitant salivary carcinoma (20). This evidence concerns the gene IGF2 and salivary gland carcinoma.